Arthur P. Staddon

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Winette T.A. van der Graaf, Jean‐Yves Blay, Sant P. Chawla et al. · The Lancet · 2012 · 2K citations · Full text

Metastatic Soft-tissue Sarcoma, Placebo-controlled Phase 3, Medicine +8

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial

George D. Demetri, Margaret von Mehren, Robin L. Jones et al. · Journal of Clinical Oncology · 2015 · 809 citations · Full text

Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study

David M. Thomas, Robert M. Henshaw, Keith M. Skubitz et al. · The Lancet Oncology · 2010 · 703 citations

Bone Disease, Malignant Disease, Medicine +7

Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study

Sant P. Chawla, Robert M. Henshaw, Leanne L. Seeger et al. · The Lancet Oncology · 2013 · 573 citations

Bone Disease, Interim Analysis, Surgical Oncology +9

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

William D. Tap, Zev A. Wainberg, Stephen P. Anthony et al. · New England Journal of Medicine · 2015 · 571 citations